Stromal thrombospondin-1 expression is a prognostic indicator and a new marker of invasiveness in intraductal papillary-mucinous neoplasm of the pancreas

Biomedical Research

Volumn 31, Issue 1, 2010, Pages 13-19

  Okada, Ken Ichi ^a   Hirabayashi, Kenichi ^a   Imaizumi, Toshihide ^a   Matsuyama, Masahiro ^a   Yazawa, Naoki ^a   Dowaki, Shoichi ^a   Tobita, Kosuke ^a   Ohtani, Yasuo ^a   Tanaka, Makiko ^a   Inokuchi, Sadaki ^a   Makuuchi, Hiroyasu ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN 1;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; PANCREAS CANCER; PAPILLARY CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL;

EID: 77749301240     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.31.13     Document Type: Article

References (25)

1. Adsay NV (2007) Cystic lesions of the pancreas. Mod Pathol 20, S71-93.
2. Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD, Sarkar FH, Hruban RH and Klimstra DS (2004) Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 28, 839-848.
3. Baenziger NL, Brodie GN and Majerus PW (1971) A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci USA 68, 240-243.
4. Bornstein P (1992) Thrombospondins: structure and regulation of expression. FASEB J 6, 3290-3299.
5. Chadwick B, Willmore-Payne C, Tripp S, Layfield LJ, Hirschowitz S and Holden J (2009) Histologic, immunohistochemical, and molecular classification of 52 IPMNs of the pancreas. Appl Immunohistochem Mol Morphol 17, 31-39.
6. Dameron KM, Volpert OV, Tainsky MA and Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584.
7. Fukushima N, Kikuchi Y, Nishiyama T, Kudo A and Fukayama M (2008) Periostin deposition in the stroma of invasive and intraductal neoplasms of the pancreas. Mod Pathol 21, 1044-1053.
8. Fukushima N, Sakamoto M and Hirohashi S (2001) Expression of laminin-5-gamma-2 chain in intraductal papillarymucinous and invasive ductal tumors of the pancreas. Mod Pathol 14, 404-409.
9. Furukawa T, Klöppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, Hruban RH, Kato Y, Klimstra DS, Longnecker DS, Lüttges J, Offerhaus GJ, Shimizu M, Sunamura M, Suriawinata A, Takaori K and Yonezawa S (2005) Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 447, 794-799.
10. Grossfeld GD, Shi SR, Ginsberg DA, Rich KA, Skinner DG, Taylor CR and Cote RJ (1996) Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 44, 761-766.
11. Hibi Y, Fukushima N, Tsuchida A, Sofuni A, Itoi T, Moriyasu F, Mukai K and Aoki T (2007) Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 34, 197-204.
12. Hruban RH and Adsay NV (2009) Molecular classification of neoplasms of the pancreas. Hum Pathol 40, 612-623.
13. Ishida M, Egawa S, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Sunamura M, Unno M, Moriya T, Horii A and Furukawa T (2007) Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Pancreas 35, 348-352.
14. Nakagohri T, Asano T, Kenmochi T, Urashima T and Ochiai T (2002) Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas. World J Surg 26, 1166-1169.
15. Nara S, Shimada K, Kosuge T, Kanai Y and Hiraoka N (2008) Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol 32, 243-255.
16. Roberts DD (1996) Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J 10, 1183-1191.
17. Sanada Y, Kunita S and Yoshida K (2008) Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas. Oncol Rep 19, 1435-1443.
18. Sargiannidou I, Zhou J and Tuszynski GP (2001) The role of thrombospondin-1 in tumor progression. Exp Biol Med (Maywood) 226, 726-733.
19. Suzuki Y, Atomi Y, Sugiyama M, Isaji S, Inui K, Kimura W, Sunamura M, Furukawa T, Yanagisawa A, Ariyama J, Takada T, Watanabe H and Suda K; Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor (2004) Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 28, 241-246.
20. Takaori K (2007) Current understanding of precursors to pancreatic cancer. J Hepatobiliary Pancreat Surg 14, 217-223.
21. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K and Matsuno S; International Association of Pancreatology (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6, 17-32.
22. Tobita K, Kijima H, Dowaki S, Oida Y, Kashiwagi H, Ishii M, Sugio Y, Sekka T, Ohtani Y, Tanaka M, Inokuchi S and Makuuchi H (2002) Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma. Int J Oncol 21, 1189-1195.
23. World Health Organization (1996) International Histological Classification of Tumours, 2 nd ed., Springer, Berlin /Japan Pancreas Society (2009) General Rules for the Study of Pancreatic Cancer, 6 th ed., Kanehara, Tokyo.
24. Yamaguchi K, Nakamura M, Shirahane K, Kawamoto M, Konomi H, Ohta M and Tanaka M (2005) Pancreatic juice cytology in IPMN of the pancreas. Pancreatology 5, 416-421
25. Yonezawa S, Nakamura A, Horinouchi M and Sato E (2002) The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepatobiliary Pancreat Surg 9, 328-341.